Jennison Associates LLC acquired a new stake in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 75,000 shares of the company's stock, valued at approximately $1,869,000. Jennison Associates LLC owned approximately 0.15% of Kestra Medical Technologies at the end of the most recent quarter.
Separately, Caas Capital Management LP purchased a new stake in shares of Kestra Medical Technologies in the first quarter valued at about $1,470,000.
Analysts Set New Price Targets
A number of research firms have recently issued reports on KMTS. The Goldman Sachs Group reduced their price target on shares of Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating for the company in a research report on Wednesday, April 16th. Wells Fargo & Company cut their price objective on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a research report on Thursday, July 17th. Wolfe Research started coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They set an "outperform" rating and a $29.00 price target for the company. Bank of America initiated coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They issued a "buy" rating and a $30.00 price objective for the company. Finally, Stifel Nicolaus assumed coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They set a "buy" rating and a $28.00 price target on the stock. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Kestra Medical Technologies has an average rating of "Moderate Buy" and a consensus target price of $27.33.
Read Our Latest Analysis on Kestra Medical Technologies
Kestra Medical Technologies Stock Performance
KMTS stock traded down $0.42 during trading hours on Friday, hitting $16.55. The company's stock had a trading volume of 174,917 shares, compared to its average volume of 535,284. The stock has a 50 day moving average of $18.22. The company has a quick ratio of 6.72, a current ratio of 6.72 and a debt-to-equity ratio of 0.20. Kestra Medical Technologies, Ltd. has a 12 month low of $13.25 and a 12 month high of $26.15.
About Kestra Medical Technologies
(
Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Further Reading
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access